Product Program year 2025 Source: CMS Open Payments

Crit-Line

Device System, Hemodialysis, Access Recirculation Monitoring

PDI 00840861101122

Open in the dashboard

General payments

$43,633

281 payments

Research payments

$4,800

1 payment

Through program year 2025, $43,633 in general payments and $4,800 in research payments were reported against Crit-Line (System, Hemodialysis, Access Recirculation Monitoring).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $1,981 55
2024 General $6,282 73
2023 General $6,952 31
2022 General $21,780 84
2021 General $6,638 38
2021 Research $4,800 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Fresenius USA Marketing, Inc. $43,458 272 payments
  2. NxStage Medical, Inc. $175 9 payments
Top recipients General payments · program year 2025
  1. James McCabe Nephrology · Wilmington, NC $500 25% · 1 payment
  2. James Henry Nephrology · Fort Smith, AR $98 5% · 1 payment
  3. Charles Moussallem Nephrology · Fort Smith, AR $98 5% · 1 payment
  4. Dana Rabideau Nephrology · Fort Smith, AR $98 5% · 1 payment
  5. Vimal Derebail Nephrology · Chapel Hill, NC $34 2% · 1 payment

The top 5 of 55 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $1,611 83% · 38 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $102 5% · 5 practitioners
  3. Internal Medicine $90 5% · 4 practitioners
  4. Nurse Practitioner $37 2% · 2 practitioners
  5. Nurse Practitioner, Acute Care Nurse Practitioner $25 1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $1,106 56% · 24 recipients
  2. Arkansas $295 15% · 3 recipients
  3. Mississippi $175 9% · 9 recipients
  4. Florida $108 5% · 5 recipients
  5. Missouri $89 4% · 5 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

281 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record